Local psychiatric hospital Sheppard Pratt is partnering with a fast-growing mental health care company to build out a center dedicated to research of psychedelic drugs. COMPASS Pathways plc (Nasdaq: CMPS), a United Kingdom-based company developing psychedelic mental health therapies, is establishing its first Centre of Excellence in collaboration with the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics.
Sheppard Pratt to renovate part of Towson campus for psychedelics research center
February 17, 2021
